Dr. Guillermo Morales

Dr. Guillermo Morales, PhD, MBA, is the CEO of Innoventyx, an international pharmaceutical and biotech consulting firm. With 30 years of experience in drug discovery, development, and software innovation, he has held leadership roles including CEO, CSO, COO, CBO, VP, and Director. He has collaborated with startups, mid-sized, and large pharmaceutical and biotech companies, research institutes, and life science software and service providers. An entrepreneur and cofounder of multiple drug and technology companies, he has raised millions from VCs and government grants while advising investors and research organizations. He has overseen diverse research programs from concept through clinical trials to commercialization, spanning oncology, CNS disorders, anti-infectives, and rare diseases. Lead inventor on nine granted patents, with several additional applications under prosecution, he served as Editor-in-Chief of Molecular Diversity for 11 years, is an NIH SBIR/STTR grant reviewer, and a US Air Force Honorary Commander.